Back to Journals » Neuropsychiatric Disease and Treatment » Volume 8 » default

Neuropsychiatric Disease and Treatment

ISSN: 1178-2021


Archive: Volume 8, 2012

Disability in patients consulting for anxiety or mood disorders in primary care: response to antidepressant treatment

Gérard A, Liard F, Crochard A, Goni S, Millet B

Neuropsychiatric Disease and Treatment 2012, 8:605-614

Published Date: 13 December 2012

The association of drooling and health-related quality of life in children with cerebral palsy

Chang SC, Lin CK, Tung LC, Chang NY

Neuropsychiatric Disease and Treatment 2012, 8:599-604

Published Date: 11 December 2012

Relationship between severity of obsessive-compulsive symptoms and schizotypy in obsessive-compulsive disorder

Yamamoto H, Tsuchida H, Nakamae T, Nishida S, Sakai Y, Fujimori A, Narumoto J, Wada Y, Yoshida T, Taga C, Fukui K

Neuropsychiatric Disease and Treatment 2012, 8:579-583

Published Date: 6 December 2012

Galantamine versus donepezil in Chinese patients with Alzheimer’s disease: results from a randomized, double-blind study

Zhang Z, Yu L, Gaudig M, Schäuble B, Richarz U

Neuropsychiatric Disease and Treatment 2012, 8:571-577

Published Date: 4 December 2012

Help-seeking behavior among Japanese school students who self-harm: results from a self-report survey of 18,104 adolescents

Watanabe N, Nishida A, Shimodera S, Inoue K, Oshima N, Sasaki T, Inoue S, Akechi T, Furukawa TA, Okazaki Y

Neuropsychiatric Disease and Treatment 2012, 8:561-569

Published Date: 22 November 2012

Reproductive life events and Alzheimer’s disease in Italian women: a retrospective study

Zucchella C, Sinforiani E, Citterio A, Giarracca V, Bono G, Mauri M

Neuropsychiatric Disease and Treatment 2012, 8:555-560

Published Date: 21 November 2012

Usefulness of milnacipran in treating phantom limb pain

Nagoshi Y, Watanabe A, Inoue S, Kuroda T, Nakamura M, Matsumoto Y, Fukui K

Neuropsychiatric Disease and Treatment 2012, 8:549-553

Published Date: 20 November 2012

Comparison of facial expression in patients with obsessive-compulsive disorder and schizophrenia using the Facial Action Coding System: a preliminary study

Bersani G, Bersani FS, Valeriani G, Robiony M, Anastasia A, Colletti C, Liberati D, Capra E, Quartini A, Polli E

Neuropsychiatric Disease and Treatment 2012, 8:537-547

Published Date: 18 December 2012

Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies

Kristinsson J, Snaedal J, Tórsdóttir G, Jóhannesson T

Neuropsychiatric Disease and Treatment 2012, 8:515-521

Published Date: 2 November 2012

Can headache impair intellectual abilities in children? An observational study

Esposito M, Pascotto A, Gallai B, Parisi L, Roccella M, Marotta R, Lavano SM, Gritti A, Mazzotta G, Carotenuto M

Neuropsychiatric Disease and Treatment 2012, 8:509-513

Published Date: 1 November 2012

Effect of triiodothyronine (T3) augmentation of acute milnacipran administration on monoamine levels: an in vivo microdialysis study in rats

Kitaichi Y, Inoue T, Nakagawa S, Boku S, Kato A, Kusumi I, Koyama T

Neuropsychiatric Disease and Treatment 2012, 8:501-507

Published Date: 30 October 2012

Effects of repetitive transcranial magnetic stimulation on clinical, social, and cognitive performance in postpartum depression

Myczkowski ML, Dias AM, Luvisotto T, Arnaut D, Bellini BB, Mansur CG, Rennó J, Tortella G, Ribeiro PL, Marcolin MA

Neuropsychiatric Disease and Treatment 2012, 8:491-500

Published Date: 25 October 2012

Effectiveness of sensory processing strategies on activity level in inclusive preschool classrooms

Lin CL, Min YF, Chou LW, Lin CK

Neuropsychiatric Disease and Treatment 2012, 8:475-481

Published Date: 23 October 2012

New developments in the treatment of partial-onset epilepsy

Besag FM, Patsalos PN

Neuropsychiatric Disease and Treatment 2012, 8:455-464

Published Date: 17 October 2012

EACOL (Scale of Evaluation of Reading Competence by the Teacher): evidence of concurrent and discriminant validity

Cogo-Moreira H, Ploubidis GB, de Ávila CR, Mari JJ, Pinheiro AM

Neuropsychiatric Disease and Treatment 2012, 8:443-454

Published Date: 11 October 2012

Parkinson’s disease patients’ subjective descriptions of characteristics of chronic pain, sleeping patterns and health-related quality of life

Skogar Ö, Fall P-A, Hallgren G, Bringer B, Carlsson M, Lennartsson U, Sandbjörk H, Törnhage C-J, Lökk J

Neuropsychiatric Disease and Treatment 2012, 8:435-442

Published Date: 12 October 2012

Stimulus-dependent effects on right ear advantage in schizophrenia

Smucny J, Wylie K, Tregellas J

Neuropsychiatric Disease and Treatment 2012, 8:423-427

Published Date: 21 September 2012

Behavioral interactions of simvastatin and fluoxetine in tests of anxiety and depression

Santos T, Baungratz MM, Haskel SP, de Lima DD, da Cruz JN, Dal Magro DD, da Cruz JG

Neuropsychiatric Disease and Treatment 2012, 8:413-422

Published Date: 1 October 2012

Oxybutynin reduces sweating in depressed patients treated with sertraline: a double-blind, placebo-controlled, clinical study

Ghaleiha A, Jahangard L, Sherafat Z, Ahmadpanah M, Brand S, Holsboer-Trachsler E, Bajoghli H, Haghighi M

Neuropsychiatric Disease and Treatment 2012, 8:407-412

Published Date: 14 September 2012

Reducing serum cholesterol levels in women

Lozano R

Neuropsychiatric Disease and Treatment 2012, 8:405-406

Published Date: 12 September 2012

Chronic shoulder pain referred from thymic carcinoma: a case report and review of literature

Dee SW, Kao MJ, Hong CZ, Chou LW, Lew HL

Neuropsychiatric Disease and Treatment 2012, 8:399-403

Published Date: 4 September 2012

OPLS statistical model versus linear regression to assess sonographic predictors of stroke prognosis

Fathi Vajargah K, Sadeghi-Bazargani H, Mehdizadeh-Esfanjani R, Savadi-Oskouei D, Farhoudi M

Neuropsychiatric Disease and Treatment 2012, 8:387-392

Published Date: 30 August 2012

Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia

Sliwa JK, Bossie CA, Fu D-J, Turkoz I, Alphs L

Neuropsychiatric Disease and Treatment 2012, 8:375-385

Published Date: 27 August 2012

Depressive symptoms and childhood sleep apnea syndrome

Carotenuto M, Esposito M, Parisi L, Gallai B, Marotta R, Pascotto A, Roccella M

Neuropsychiatric Disease and Treatment 2012, 8:369-373

Published Date: 23 August 2012

Transdermal donepezil on the treatment of Alzheimer's disease

Sozio P, Cerasa LS, Marinelli L, Di Stefano A

Neuropsychiatric Disease and Treatment 2012, 8:361-368

Published Date: 20 August 2012

Aggressive behavior, cognitive impairment, and depressive symptoms in elderly subjects

Margari F, Sicolo M, Spinelli L, Mastroianni F, Pastore A, Craig F, Petruzzelli MG

Neuropsychiatric Disease and Treatment 2012, 8:347-353

Published Date: 1 August 2012

Acute neuropsychiatric disorders in adolescents and young adults with Down syndrome: Japanese case reports

Akahoshi K, Matsuda H, Funahashi M, Hanaoka T, Suzuki Y

Neuropsychiatric Disease and Treatment 2012, 8:339-345

Published Date: 30 July 2012

Major depressive disorders in chronic hemodialysis patients in Nazareth: identification and assessment

Armaly Z, Farah J, Jabbour A, Bisharat B, Abd-El Qader A, Saba S, Zaher M, El Haj E, Hamzi M, Bowirrat A

Neuropsychiatric Disease and Treatment 2012, 8:329-338

Published Date: 25 July 2012

5-HTP efficacy and contraindications

Hinz M, Stein A, Uncini T

Neuropsychiatric Disease and Treatment 2012, 8:323-328

Published Date: 19 July 2012

Editor's choice

Pinder RM

Neuropsychiatric Disease and Treatment 2012, 8:321-322

Published Date: 20 July 2012

Pattern sensitivity: a missed part of the diagnosis

El Shakankiry HM, Abdel Kader AA

Neuropsychiatric Disease and Treatment 2012, 8:313-319

Published Date: 17 July 2012

Copy number variants in a sample of patients with psychotic disorders: is standard screening relevant for actual clinical practice?

Van de Kerkhof NW, Feenstra I, van der Heijden FM,  De Leeuw N, Pfundt R, Stöber G, Egger JI, Verhoeven WM

Neuropsychiatric Disease and Treatment 2012, 8:295-300

Published Date: 12 July 2012

Longitudinal course of deficient emotional self-regulation CBCL profile in youth with ADHD: prospective controlled study

Biederman J, Spencer TJ, Petty C, Hyder LL, O'Connor KB, Surman CBH, Faraone SV

Neuropsychiatric Disease and Treatment 2012, 8:267-276

Published Date: 25 June 2012

Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis

Ye W, Ascher-Svanum H, Tanji Y, Flynn JA, Takahashi M, Conley RR

Neuropsychiatric Disease and Treatment 2012, 8:259-266

Published Date: 18 June 2012

Role of aripiprazole in treatment-resistant schizophrenia

Mossaheb N, Kaufmann RM

Neuropsychiatric Disease and Treatment 2012, 8:235-244

Published Date: 29 May 2012

Sleep paralysis in medieval Persia – the Hidayat of Akhawayni (? –983 AD)

Golzari SE, Khodadoust K, Alakbarli F, Ghabili K, Islambulchilar Z, Shoja MM, Khalili M, Abbasnejad F, Sheikholeslamzadeh N, Shahabi NM, Hosseini SF, Ansarin K,

Neuropsychiatric Disease and Treatment 2012, 8:229-234

Published Date: 6 June 2012

Teenage outcomes after speech and language impairment at preschool age

Ek U, Norrelgen F, Westerlund J, Dahlman A, Hultby E, Fernell E

Neuropsychiatric Disease and Treatment 2012, 8:221-227

Published Date: 15 May 2012

Optimal treatment of social phobia: systematic review and meta-analysis

Canton J, Scott KM, Glue P

Neuropsychiatric Disease and Treatment 2012, 8:203-215

Published Date: 3 May 2012

Cortical mapping with navigated transcranial magnetic stimulation in low-grade glioma surgery

Paiva WS, Fonoff ET, Marcolin MA, Cabrera HN, Teixeira MJ

Neuropsychiatric Disease and Treatment 2012, 8:197-201

Published Date: 3 May 2012

The association of C3435T single-nucleotide polymorphism, Pgp-glycoprotein gene expression levels and carbamazepine maintenance dose in patients with epilepsy

Sterjev Z, Trencevska GK, Cvetkovska E, Petrov I, Kuzmanovski I, Ribarska JT, Nestorovska AK, Matevska N, Naumovska Z, Jolevska-Trajkovic S, Dimovski A, Suturkova L

Neuropsychiatric Disease and Treatment 2012, 8:191-196

Published Date: 19 April 2012

The role of paliperidone extended release for the treatment of bipolar disorder

Marino J, English C, Caballero J, Harrington C

Neuropsychiatric Disease and Treatment 2012, 8:181-189

Published Date: 20 April 2012

Phelan-McDermid syndrome in two adult brothers: atypical bipolar disorder as its psychopathological phenotype?

Verhoeven WMA, Egger JIM, Willemsen MH, de Leijer GJM, Kleefstra T

Neuropsychiatric Disease and Treatment 2012, 8:175-179

Published Date: 19 April 2012

Is this a new type of primary prosopagnosia, both progressive and apperceptive?

Sugimoto A, Koyama S, Midorikawa A, Futamura A, Ishiwata K, Ishii K, Miller MW, Kawamura M

Neuropsychiatric Disease and Treatment 2012, 8:169-173

Published Date: 18 April 2012

Critical appraisal of lurasidone in the management of schizophrenia

Caccia S, Pasina L, Nobili A

Neuropsychiatric Disease and Treatment 2012, 8:155-168

Published Date: 17 April 2012

Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia

Goto N, Yoshimura R, Kakeda S, Nishimura J, Moriya J, Hayashi K, Katsuki A, Hori H, Umene-Nakano W, Ikenouchi-Sugita A, Korogi Y, Nakamura J

Neuropsychiatric Disease and Treatment 2012, 8:119-122

Published Date: 3 April 2012

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia

Ascher-Svanum H, Brnabic AJM, Lawson AH, Kinon BJ, Stauffer VL, Feldman PD, Kelin K

Neuropsychiatric Disease and Treatment 2012, 8:113-118

Published Date: 15 March 2012

Update on the role of antipsychotics in the treatment of Tourette syndrome

Huys D, Hardenacke K, Poppe P, Bartsch C, Baskin B, Kuhn J

Neuropsychiatric Disease and Treatment 2012, 8:95-104

Published Date: 12 March 2012

Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy

Gold M, Lorenzl S, Stewart AJ, Morimoto BH, Williams DR, Gozes I

Neuropsychiatric Disease and Treatment 2012, 8:85-93

Published Date: 9 February 2012

Neuroimmune endocrine effects of antidepressants

Antonioli M, Rybka J, Carvalho LA

Neuropsychiatric Disease and Treatment 2012, 8:65-83

Published Date: 7 February 2012

ECT, rTMS, and deepTMS in pharmacoresistant drug-free patients with unipolar depression: a comparative review

Minichino A, Bersani FS, Capra E, Pannese R, Bonanno C, Salviati M, Delle Chiaie R, Biondi M

Neuropsychiatric Disease and Treatment 2012, 8:55-64

Published Date: 16 January 2012

Reduced reward-related probability learning in schizophrenia patients

Yılmaz A, Simsek F, Gonul AS

Neuropsychiatric Disease and Treatment 2012, 8:27-34

Published Date: 5 January 2012

Electroencephalography in eating disorders

Jáuregui-Lobera I

Neuropsychiatric Disease and Treatment 2012, 8:1-11

Published Date: 28 December 2011